Metacrine Inc (MTCR) Stock

DelistedNasdaq: MTCRMetacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases.

0.49
Final close · Feb 8, 2023

MTCR is no longer traded. Metacrine Inc was delisted from the Nasdaq in February 2023.

Prices on this page are historical; the last trade was February 8, 2023 at $0.49.

Metacrine Inc stock price history

Split-adjusted closes, 2020–2023

MTCR final trading statistics

Final close
$0.49
Final trading day
Feb 8, 2023
Market cap at delisting
$21.69M
Shares outstanding
43.83M
Final 52-week range
$0.30 – $0.68
Avg. volume (final 3 mo.)
407,775
All-time high (split-adj.)
$11.76 · Sep 2020
All-time low (split-adj.)
$0.35 · Oct 2022
Return since IPO
-95.8%
Beta
-0.74
Book value / share
$0.87
Price / book
0.57
Final 52 wk
0.300.68

Metacrine Inc earnings per share

Earnings per share

Metacrine Inc revenue & net income

RevenueNet income

Metacrine Inc annual financials

Metacrine Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2021$0.00-$61.2M-$2.17
FY2020$0.00-$36.0M-$3.22
FY2019$0.00-$29.3M—
FY2018$1.45M-$25.8M—

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Metacrine Inc

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Metacrine Inc stock FAQ

What happened to Metacrine Inc stock?

Metacrine Inc stock was delisted from the Nasdaq. Its final close was $0.49 on February 8, 2023.

Is MTCR stock still trading?

No. MTCR was delisted from the Nasdaq in February 2023 and no longer trades on a U.S. exchange.

What was the last price of MTCR stock?

MTCR closed at $0.49 on its final trading day, February 8, 2023, for a market value of about $21.69M.

What were Metacrine Inc's revenue and earnings in its last full fiscal year?

Metacrine Inc reported revenue of $0.00 and net income of -$61.2M in fiscal 2021, its last full year as a public company.

When did Metacrine Inc go public?

Metacrine Inc stock began trading on September 16, 2020.

stocks to research